Skip to content

Clinical trials

Phase 1 Mesothelioma, Malignant trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mesothelioma, Malignant Phase: Phase 1 Country / region: United States Clear all

61 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20021
20033
20041
20063
20073
20081
20091
20102
20112
20121
20141
20152
20162
20172
20183
20194
20204
20214
20222
20232
20243
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Terminated11
Recruiting8
Active, not recruiting5
Withdrawn4
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)11
Memorial Sloan Kettering Cancer Center7
M.D. Anderson Cancer Center6
Abramson Cancer Center at Penn Medicine3
University of Pennsylvania3
Mayo Clinic2
National Institutes of Health Clinical Center (CC)2
Roswell Park Cancer Institute2
University of Chicago2
Aduro Biotech, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mesothelioma, Malignant61
Carcinoma, Non-Small-Cell Lung17
Lung Neoplasms11
Mesothelioma10
Carcinoma, Ovarian Epithelial8
Fallopian Tube Neoplasms8
Neoplasms7
Ovarian Neoplasms7
Pancreatic Neoplasms7
Uterine Cervical Neoplasms7

Trials

Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.